Minghui Pharmaceutical has announced an exclusive licensing and partnership agreement with Qilu Pharmaceutical for MHB088C in ...

The Danish multinational said that Sogroya improved the yearly growth rate in pre-pubertal children born small for ...

The executive order aims to cut US prescription drug costs by linking them to the lowest prices paid internationally.

Both the FDA and EMA have suspended Ixchiq’s use in older adults after post-marketing serious adverse events that include two ...

Eli Lilly and Purdue University, US, have announced the widening of their existing partnership with a planned investment of ...

LENZ has announced an exclusive licensing and commercialisation agreement with Lotus Pharmaceutical of Taiwan.

Isolator lines present several significant advantages for large-scale aseptic filling, as Marcel Langner of IDT Biologika ...

AAN conference featured the latest research and developments in neurological disorders like Alzheimer's disease, epilepsy and ...

HLS Therapeutics has signed an agreement with Esperion Therapeutics for commercialising Nexletol and Nexlizet in Canada.

This move comes a day after President Trump signed an executive order to streamline approval processes for domestic plants.

Viralgen has partnered biotech company Trogenix, aiming to accelerate the development of gene therapy for glioblastoma.

Developing orphan drugs involves navigating intricate regulatory landscapes, financial risks, and limited clinical data. To ...